About
CEO of the Parker Institute for Cancer Immunotherapy and former CEO of the American Cancer Society. Serves on the boards of AstraZeneca and several biotech companies.
Experience
- Parker Institute for Cancer ImmunotherapyChief Executive Officer and Executive Directorcurrent2025 β present
- AstraZenecaBoard Membercurrent2025 β present
- Exai BioBoard Membercurrent2024 β present
- Paradigm HealthBoard Membercurrent2025 β present
- 3T BiosciencesBoard Membercurrent2025 β present
- ArteraAIBoard Advisorcurrent2023 β present
- TranscarentStrategic Advisor, Cancer Carecurrent2025 β present
- CellCentricAdvisory Board Membercurrent2025 β present
- GenentechAdvisory Board Membercurrent2019 β present
- Thomas Jefferson UniversityProfessor Emeritacurrent2020 β present
- Thomas Jefferson UniversityEndowed Professor of Cancer Biology, Radiation Oncology, Urology, and Medical Oncologycurrent2007 β present
- Thomas Jefferson UniversityChair and Hilary Koprowski Professor, Department of Cancer Biology2015 β 2021
- Thomas Jefferson UniversityDeputy Director, NCI-designated Sidney Kimmel Cancer Center2012 β 2015Philadelphia, PA
- Thomas Jefferson UniversityVice Provost2014 β 2015
- Research!America: Discovery. Innovation. Health.Board Member2023 β 2025
- American Cancer SocietyExecutive Strategic Advisor & Immediate Past CEO2024 β 2025
- American Cancer SocietyCEO, American Cancer Society and American Cancer Society Action Network2021 β 2024
- National Cancer Institute (NCI)Board Member, Board of Scientific Advisors2018 β 2024
- Association of American Cancer InstitutesPresident and Board Chair2020 β 2021
- Association of American Cancer InstitutesPresident Elect2018 β 2020
Education
- UC San DiegoDoctor of Philosophy (Ph.D.), Molecular Biology1991 β 1996
- Fox School of Business at Temple UniversityMaster of Business Administration - MBA2018 β 2019
- The George Washington UniversityBS Biology1987 β 1990
Skills & more
Board Governance1Board LevelBoard level experienceNon-profit Board LeadershipBoard LeadershipResearch33Training5Academic Medicine5Cancer Research29Healthcare19Cancer41Management13
+1 more
LeadershipFrom Karen's professional profile.
Same school
Also attended UC San Diego187
Mark SusterManaging Partner at Upfront VenturesBirgitteInvestor at InvestinorHouman HaghighiPartner, Business & Corporate Development at Menlo VenturesFreya Svedberg-KeatingInvestor at MedicxiJamie MontgomeryCo-Founder & Managing Partner at March Capital PartnersAbbie CelnikerInvestor at Third Rock Ventures
+ 181 more
Also attended Fox School of Business at Temple University9
Angelo VallettaPresident & CEO at Ben Franklin Technology PartnersMahmood IbrahimPartner - Investor Relations at Signal Peak VenturesChi PhamProduct Designer at 25MadisonSreeja NairFund Controller at TrueBridge Capital PartnersOfo EzeugwuEntrepreneur in Residence at Quake CapitalJeffrey W GriffithsAngel at Broad Street Angels
+ 3 more
Also attended The George Washington University146
RustyAdvisor at Clear VenturesDonna HoyleVice President & Controller at RevolutionMathew KayeAccounting Manager at RevolutionMeghan FahyDirector of Marketing at GreycroftMaurice RussoInvestor at Lerer HippeauChristina PasanenInvestor at GGV Capital
+ 140 more
Shared employers
Also worked at AstraZeneca52
Jung Lee, PhDVenture Partner at Adelphi Ventures Management, LlcJohan LundVenture Partner at ScietyAnnie VemuSenior Associate at Longwood FundIliam BarkinoInvestor at IndustrifondenSara JawadInvestor at IndustrifondenDamian Crowtherex-AstraZeneca at PICUS CAPITAL
+ 46 more
Also worked at 3T Biosciences1
Also worked at University of Cincinnati9
Emma OffCEO, President, & Partner at CincyTechRyan HaysBoard Member at CincyTechShashank SaxenaInvestor at Sierra VenturesRajat BhageriaPartner at Afore CapitalChristin GodaleInvestor at CincyTechDeborah TekleAnalyst at CincyTech
+ 3 more
Also worked at Ludwig Institute for Cancer Research3
Colleagues at Oncology Ventures
Ben Freeberg
Founder, Managing Partner at Oncology Ventures
Brad Hively
Advisor at Oncology Ventures
Carolyn Starrett
Advisor at Oncology Ventures
David Cohn
Interim Chief Executive Officer and Chief Medical Officer at Oncology Ventures
Diana Verrilli
General Manager, Navista (a Cardinal Health company) at Oncology Ventures
Emily Melton
Investor at Threshold Ventures
Harlan Levine
President of Health Innovation and Policy at Oncology Ventures
Jason Shook
Chief Operating Officer at Oncology Ventures








.jpg)
































